| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |